Navigation Links
Halo Pharmaceutical Welcomes Al Rosenston as its Vice President, Business Development
Date:1/26/2009

WHIPPANY, N.J., Jan. 26 /PRNewswire/ -- Adding to its strong executive team, Halo Pharmaceutical today announced the addition of Allen M. Rosenston, a thirty-five year pharmaceutical industry veteran, as Halo's new Vice President of Business Development. Al comes to Halo from a long and distinguished career at Abbott Laboratories where he held diverse roles in operations, business development, and related business functions. "The addition of Al to the Halo business development team is a significant achievement. Al has deep experience within the pharmaceutical industry. He developed Abbott's domestic Contract Pharmaceutical Manufacturing Business Unit and, at the time of his retirement, he was responsible for the global finished goods contract manufacturing business," according to Mohd Asif, Halo's Chief Financial Officer.

Al comes to Halo shortly after Halo's acquisition of its Whippany, NJ facility, a facility which has been producing various dosage forms for 35 years. "I am thrilled to be part of the Halo Pharmaceutical team, and to build on the legacy of this outstanding facility and group of talented people with an average seniority of over 20 years. Based on my discussions with the new Halo team, this is a unique opportunity to create a world-class pharmaceutical services company right in the heart of New Jersey. Maintaining focus on quality, service, and compliance, along with the flexible manufacturing capabilities of the Whippany facility, will create a high-level of interest with prospective customers. I anticipate us to be highly competitive when overall service value is assessed."

Halo capabilities include an impressive array of formulation services, operations for the aseptic filling of topical ointments, solid dosage forms (tablets and capsules), liquids, suppositories, associated packaging (tablet, powder, liquids and HUD) and ample laboratory space for formulation development, pre-clinical and clini
'/>"/>

SOURCE Halo Pharmaceutical
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. KV Pharmaceutical Suspends Product Manufacturing, Shipping
2. KV Pharmaceuticals Launch of Gestiva(TM) Delayed
3. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
4. Caraco Pharmaceutical Laboratories, Ltd. to Announce Third Quarter of Fiscal Year 2009 Results on January 29, 2009
5. University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing
6. Amylin Pharmaceuticals to Webcast Year-End Results
7. Renhuang Pharmaceuticals, Inc. Engages New Independent Auditor
8. Abbott Opens New Pharmaceutical Research Laboratory in Singapore
9. Law Firm Freedland Russo Spearheads Record-Setting Whistleblower Case Against Pharmaceutical Giant Eli Lilly -- Firm Expands Offices to Include L.A. Entertainment Branch
10. NUCRYST Pharmaceuticals appoints a new director
11. Peptimmune Grants Major Pharmaceutical Company Exclusive Option to License PI-2301 for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Ticket Down is a reputable source for 2015 Cleveland ... hot during the 2014-15 NBA season and they delighted their fan ... score of 118-88. , For the Cavaliers, this is ... they lost to the San Antonio Spurs. Once Lebron James ... making it to the NBA finals increased tenfold. The team ...
(Date:5/27/2015)... “We are honored to receive this gift ... and vice president of clinical affairs for SSCHC. “The ... to provide comprehensive care to more individuals and improve ... clinical care and behavioral health services for Milwaukee’s vulnerable ... of whom took advantage of the clinic’s behavioral health ...
(Date:5/27/2015)... 27, 2015 Continuing its commitment to ... patients in the community, SmartPractice® donated $25,000 ... C. Lincoln). SmartPractice Vice President of Human Resources Meg ... a $25,000 check to Paulla Miller, Sherry Gage, Dr. ... & Research Center on April 30. The center is ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 In today's ... getting tighter, it can be challenging for doctors and ... cutting edge treatments. , Austin-based HealthTronics, Inc. ... minimally invasive, mobile medical therapies for clinically sophisticated applications. ... with the acquisition of Laser Ventures, Inc ., ...
(Date:5/27/2015)... The new http://www.carsonenergy.com includes ... should consider oil and gas investing, the substantial tax ... drilled, industry news, IRA investing, definitions and acronyms, info-graphics ... knowledge and experience is now in one central location, ... able to access 24 hours a day, 7 days ...
Breaking Medicine News(10 mins):Health News:Cavs NBA Finals Tickets: Ticket Down Slashes Ticket Prices on Cleveland Cavaliers 2015 NBA Finals Tickets at Quicken Loans Arena and Offers Valuable Promo Code 2Health News:Sixteenth Street Community Health Centers To Expand Primary Care and Behavioral Health Services Through $1 Million Grant From Aurora's Better Together Fund 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:Carson Energy Launches Next Generation Investor Website 2
... Sept. 12 GSI Securitization,Inc. (Pink Sheets: GSIEF) ... "GSI is engaged in a,project with nine separate ... and funding for healthcare accounts receivable. This is ... for funding of receivables in the,$2-trillion+ healthcare market. ...
... If you,re one of the,millions of Texans who ... your handkerchief: Allergy researchers at Presbyterian Hospital of,Dallas say ... decades. "The unusually wet weather this summer means ... for lots of people," said Gary Gross, MD, an,allergist ...
... 2007) -- The University of South Floridas global health ... AIDS has been strengthened with a $1.36-million research training ... USF Health received the five-year grant Sept. 11 from ... training program focused on the biomedical, behavioral, cultural and ...
... Sept. 12 Navitas Cancer Rehabilitation Centers,of ... providing integrated and,comprehensive cancer rehabilitation services, is ... new center in Albuquerque, New Mexico. The ... New Mexico Oncology,Hematology Consultants, Ltd., (NMOHC) the ...
... aid children in crucial days after trauma, developers say ... now allows doctors to monitor blood flow through the ... death in children with head injuries. , Brain trauma ... States. Almost 475,000 children suffer brain injuries annually, according ...
... depends on the steady work of a vital gene that ... School cancer geneticists have found. Their research reveals an ... system, and opens novel strategies for targeting the gene, which ... , We have identified a new pathway that is essential ...
Cached Medicine News:Health News:Allergists at Presbyterian Hospital of Dallas Say This Year's Fall Allergy Season Could be Worst in Decades 2Health News:Global Health Project targets reducing AIDS among India's adolescents 2Health News:Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers 2Health News:Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers 3Health News:Imaging Software Helps Track, Treat Injured Brains 2Health News:Unique role for blood formation gene identified 2
(Date:5/27/2015)... -- Doctors from the Sheikh Zayed Institute for ... System are the first in the ... benign but painful bone tumor that commonly occurs in ... high-intensity focused ultrasound (MR-HIFU) method. Two patients, 16-year-old ... have been treated successfully in a research study aimed ...
(Date:5/27/2015)... 2015 Water Street Healthcare Partners ... health care industry, announced today that it has ... the world,s leading global health care companies. The partnership ... firm established in 2013 as a new way ... developing pharmaceutical products and medical devices. ...
(Date:5/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/9ffv95/2015_strategies ... "2015 Strategies in the European Coagulation Testing Market" ... comprehensive five-country report contains 500 pages, 120 tables, ... potential market entrants identify and evaluate business opportunities ... the next five years. The report ...
Breaking Medicine Technology:Children's National first in US to destroy bone tumors with incisionless surgery 2Children's National first in US to destroy bone tumors with incisionless surgery 3Children's National first in US to destroy bone tumors with incisionless surgery 4Water Street Announces Pharmaceutical Development Partnership with Global Health Care Company 2European Coagulation Testing Market Strategies 2015 2
... Mass., June 24 Pressure,BioSciences, Inc. (Nasdaq: ... today announced,that it has been awarded a ... (2R44GM079059-02) from the National Institutes of Health,(NIH). ... directed towards the,development and commercialization of novel, ...
... Program to Advance to the Clinic Within a Year; Studies ... Generate Milestone Payment to ... Inc. (Nasdaq: MITI ) and Nycomed today announced the ... MT203.,Micromet received $775,000 (500,000 euros) from Nycomed for the achievement,of ...
Cached Medicine Technology:Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 2Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 3Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery 4Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 2Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 3Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 4
... Oxygen Concentrator is a low decibel, low ... oxygen for prescriptions up to 5 liters ... running concentrator at <40 dBA, this unit ... Concentrators are also an economical and safe ...
... NewLife Intensity is AirSep's new high ... power special respiratory applications. This concentrator can ... NewLife Intensity can save on equipment needs ... ,Operating at 20 psig (138 kPa), with ...
... most economical line of stationary oxygen concentrators, ... oxygen in home, hospital, and clinical settings. ... daily use throughout the world, this low ... performance, easy maintenance, and unmatched reliability. (Flow ...
OCD-3000 pnuematic conserving regulator for large cylinder....
Medicine Products: